New York Ophthalmologist Sees Rapid Growth with Tixel i® Dry Eye Treatment
Editorial
1 minute
New York Ophthalmologist Sees Rapid Growth with Tixel i® Dry Eye Treatment
Dr. Noaman Sanni of Center for Sight New York has experienced significant patient and revenue growth after integrating Tixel i®, Novoxel’s FDA-cleared device for Meibomian Gland Dysfunction (MGD), into his practice. Within two months, over 225 patients received the quick, non-invasive treatment, which delivers lasting relief in under two minutes without the need for anesthesia or consumables. Dr. Debra Koloms, the clinic’s medical director, praised Tixel i® as “the most impressive treatment” she has encountered in 40 years of practice.